Perinatal Hepatitis B Virus Transmission in the United States: Prevention by Passive-Active Immunization

JAMA: The Journal of the American Medical Association

Volumn 253, Issue 12, 1985, Pages 1740-1745

  Stevens, Cladd E ^a   Toy, Pearl T ^b   Tong, Myron J ^c   Taylor, Patricia E ^a   Vyas, Girish N ^b   Nair, Prem V ^c   Gudavalli, Madhu ^d   Krugman, Saul ^d  

^a NEW YORK BLOOD CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HUNTINGTON MEMORIAL HOSPITAL   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN; INACTIVATED VIRUS VACCINE;

ACTIVE IMMUNIZATION; HUMAN; LIVER; NEWBORN; PASSIVE IMMUNIZATION; PERINATAL INFECTION; PERINATAL PERIOD; PREVENTION; PRIORITY JOURNAL; UNITED STATES; VIRUS TRANSMISSION;

ASIAN AMERICANS; CARRIER STATE; FEMALE; FETAL BLOOD; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNIZATION, PASSIVE; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION;

EID: 84944365708     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1985.03350360066020     Document Type: Article

References (48)

1. Stokes J Jr, Berk JE, Malamut LL, et al.: The carrier state in viral hepatitis. JAMA 1954;154:1059-1065.
2. Schweitzer IL, Wing A, McPeak C, et al.: Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs. JAMA 1972;220:1092-1095.
3. Stevens CE, Beasley RP, Tsui J, et al.: Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-774.
4. Okada K, Yamada T, Miyakawa Y, et al.: Hepatitis B surface antigen in the serum of infants after delivery from asymptomatic carrier mothers. J Pediatr 1975;87:360-363.
5. Gerety RJ, Schweitzer IL: Viral hepatitis type B during pregnancy, the neonatal period, and infancy. J Pediatr 1977;90:368-374.
6. Lee AKY, Ip HMH, Wong VCW: Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978;138:668-671.
7. Derso A, Boxall EH, Tarlow MJ, et al.: Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J 1978;1:949-952.
8. Tong MJ, Thursby M, Rakela J, et al.: Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology 1981;80:999-1004.
9. Shiraki K, Yoshihara N, Kawana T, et al.: Hepatitis B surface antigen and chronic hepatitis in infants born to asymptomatic carrier mothers. AJDC 1977;131:644-647.
10. Okada K, Kamiyama I, Inomata M, et al.: e Antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-749.
11. Beasley RP, Trepo C, Stevens CE, et al.: The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977;105:94-98.
12. Stevens CE, Neurath RA, Beasley RP, et al.: HBeAg and anti-HBe detection by radioimmunoassay: Correlation with veritcal transmission of hepatitis B virus in Taiwan. J Med Virol 1979;3:237-241.
13. Nishioka K, Hirhyama T, Sekine T, et al.: Australia antigen and hepatocellular carcinoma. Gann Monogr Cancer Res 1973;14:167-175.
14. Ohbayashi A, Okochi K, Mayumi M: Familial clustering of asymptomatic carriers of Australia antigens and patients with chronic liver disease or primary liver cancer. Gastroenterology 1972;62:618-625.
15. Larouze B, London WT, Saimot G, et al.: Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families: A case/control study in Senegal, West Africa. Lancet 1976;2:534-538.
16. Szmuness W: Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association. Prog Med Virol 1978;24:40-69.
17. Larouze B, Blumberg BS, London WT, et al.: Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: Studies in West Africa. JNCI 1977; 58:1557-1561.
18. Marion PL, Salazar FH, Alexander JJ, et al.: State of hepatitis B viral DNA in a human hepatoma cell line. J Virol 1980;33:795-806.
19. Edman JC, Gray P, Valenzuela P, et al.: Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature 1980;286:535-538.
20. Brechot C, Pourcel C, Louise A, et al.: Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 1980;286:533-535.
21. Shafritz DA, Shouval D, Sherman HI, et al.: Integration of heptitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 1981; 305:1067-1073.
22. Beasley RP, Hwang L-Y, Lin C-C, et al.: Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-1133.
23. Stevens CE, Szmuness W: Vertical transmission of hepatitis B and neonatal hepatitis B, in Bianchi L, Gerok W, Sickinger K, et al. (eds): Virus and the Liver. Lancaster, England, MTP Press, 1980, pp 285-291.
24. Kohler PF, Dubois RS, Merrill DA, et al.: Prevention of chronic neonatal hepatitis B virus infection with antibody to the hepatitis B surface antigen. N Engl J Med 1974;291:1378-1380.
25. Reesink HW, Reerink-Brongers EE, Lafeber-Schut BJT, et al.: Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin. Lancet 1979;2:436-438.
26. Matsumoto S, Tomigashi T, Fujimoto S, et al.: Prevention of hepatitis B infection in neonates by human anti-HBV immunoglobulin (HBIG). Perinatology 1979;9:615-622.
27. Beasley RP, Hwang L-Y, Lin C-C, et al.: Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state: Initial report of a randomised double-blind placebo-controlled trial. Lancet 1981;2:388-393.
28. Beasley RP, Hwang L-Y, Szmuness W, et al.: HBIG prophylaxis for perinatal HBV infections: Final report of the Taiwan trial. Dev Biol Stand 1983;54:363-375.
29. Hilleman MR, Buynak EB, McAleer WJ, et al.: Hepatitis A and hepatitis B vaccines, in Szmuness W, Alter HJ, Maynard JE (eds): Viral Hepatitis: 1981 International Symposium. Philadelphia, Franklin Institute Press, 1982, pp 385-397.
30. Hoofnagle JH, Gerety RJ, Smallwood LA, et al.: Subtyping of hepatitis B surface antigen and antibody to radioimmunoassay. Gastroenterology 1977;72:290-296.
31. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-170.
32. Beasley RP, Hwang L-Y: Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983;147:185-190.
33. McAuliffe VJ, Purcell RH, Gerin JL, et al.: Current status of the NIAID hepatitis B vaccines, in Szmuness W, Alter HJ, Maynard JE (eds): Viral Hepatitis: 1981 International Symposium. Philadelphia, Franklin Institute Press, 1982, pp 425-435.
34. Szmuness W, Stevens CE, Harley EJ, et al.: Hepatitis B vaccine in medical staff of hemodialysis units: Efficacy and subtype cross-protection. N Engl J Med 1982;307:1481-1486.
35. Tada H, Yanagida M, Mishina J, et al.: Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics 1982;70:613-619.
36. Beasley RP, Hwang L-Y, Lee GC-Y, et al.: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2:1099-1102.
37. Wong VCW, Ip HMH, Reesink HW, et al.: Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Lancet 1984;1:921-926.
38. Maupas P, Chiron J-P, Barin F, et al.: Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children: Controlled trial in an endemic area (Senegal). Lancet 1981;1:289-292.
39. Barin F, Goudeau A, Denis F, et al.: Immune response in neonates to hepatitis B vaccine. Lancet 1982;1:251-253.
40. Prozesky OW, Stevens CE, Szmuness W, et al.: Immune response to hepatitis B vaccine in newborns. J Infect 1983;7(suppl 1):53-55.
41. Lee GC-Y, Hwang L-Y, Beasley RP, et al.: Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates. J Infect Dis 1983; 148:526-529.
42. Szmuness W, Stevens CE, Oleszko WR, et al.: Passive-active immunisation against hepatitis B: Immunogenicity studies in adult Americans. Lancet 1981;1:575-577.
43. Szmuness W, Neurath AR, Stevens CE, et al.: Prevalence of hepatitis B ‘e’ antigen and its antibody in various HBsAg carrier populations. Am J Epidemiol 1981;113:113-121.
44. Francis DP, Maynard JE: The transmission and outcome of hepatitis A, B, and non-A, non-B: A review. Epidemiol Rev 1979;1:17-31.
45. Szmuness W, Prince AM, Brotman B, et al.: Hepatitis B antigen and antibody in blood donors: An epidemiologic study. J Infect Dis 1973;127:17-25.
46. Sinatra FR, Shah P, Weissman JY, et al.: Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigenpositive and anti-hepatitis B e-positive carrier mothers. Pediatrics 1982;70:557-559.
47. Naggan L, Gorodischer R, Bar-Shany S, et al.: Clinical hepatitis B in two infants born to asymptomatic hepatitis B surface antigen carrier mothers. Isr J Med Sci 1983;19:292-293.
48. Delaplane D, Yogev R, Crussi F, et al.: Fatal hepatitis B in early infancy: Importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics 1983;72:176-180.